Evaluating for Pseudoprogression in Colorectal and Pancreatic Tumors Treated with Immunotherapy

Pseudoprogression has been observed in patients with various tumor types treated with immunotherapy. However, the frequency of pseudoprogression is unknown in gastrointestinal malignancies. Metastatic colorectal cancer (mCRC) and advanced pancreatic ductal adenocarcinoma (PDAC) patients who progress...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Immunother
Main Authors: Parseghian, Christine M., Patnana, Madhavi, Bhosale, Priya, Hess, Kenneth R., Shih, Ya-Chen Tina, Kim, Bumyang, Kopetz, Scott, Overman, Michael J., Varadhachary, Gauri R., Javle, Milind, Naing, Aung, Piha-Paul, Sarina, Hong, David, Le, Hung, Subbiah, Vivek, Pant, Shubham
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028046/
https://ncbi.nlm.nih.gov/pubmed/29668571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0000000000000222
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares